Immune Response to a Single Simulated Post-Exposure Rabies Booster Vaccination in Six Months after Receiving Incomplete TRC-ID Regime
Not Applicable
Active, not recruiting
- Conditions
- immunogenicityboosterrabies vaccination
- Registration Number
- TCTR20131005001
- Lead Sponsor
- Queen Saovabha Memorial Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Healthy, age 18-60 years old
Willing to participate in this study
can follow the protocol study
Exclusion Criteria
- previous history of rabies immunization
- immunocompromised conditions
- Allergy to rabies vaccine or its components
- Pregnant
- Receiving blood products within 3 months
- Acute illness (Temporary exclusion criteria)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rabies Neutralizing Antibody Titers Day 192, 201, 277 Rapid Fluorescent Focus Inhibition Test
- Secondary Outcome Measures
Name Time Method safety of booster rabies vaccination Through the study local and systemic adverse reactions